https://www.aavantgarde.com/en/ 2025-11-05T13:46:41+00:00 https://www.aavantgarde.com/en/about/ 2025-11-05T13:46:28+00:00 https://www.aavantgarde.com/en/about/management-team/ 2025-07-22T15:07:47+00:00 https://www.aavantgarde.com/en/about/board-of-directors/ 2024-12-23T09:14:57+00:00 https://www.aavantgarde.com/en/about/investors/ 2025-11-05T13:46:09+00:00 https://www.aavantgarde.com/en/about/scientific-advisory-board/ 2025-01-07T13:05:12+00:00 https://www.aavantgarde.com/en/about/profiles/natalia-misciattelli/ 2026-01-05T14:44:28+00:00 https://www.aavantgarde.com/en/about/profiles/mike-heffernan/ 2025-09-02T08:16:50+00:00 https://www.aavantgarde.com/en/about/profiles/prof-alberto-auricchio/ 2025-02-06T09:50:42+00:00 https://www.aavantgarde.com/en/about/profiles/dr-jayashree-sahni/ 2024-12-23T09:13:44+00:00 https://www.aavantgarde.com/en/about/profiles/nina-kotsopoulou/ 2024-12-23T09:13:49+00:00 https://www.aavantgarde.com/en/about/profiles/rasmus-holm-jorgensen/ 2025-04-28T12:54:47+00:00 https://www.aavantgarde.com/en/about/profiles/philip-lao/ 2026-04-01T11:06:20+00:00 https://www.aavantgarde.com/en/about/profiles/magda-blanco/ 2024-12-23T09:13:58+00:00 https://www.aavantgarde.com/en/about/profiles/dmitrij-hristodorov/ 2026-02-04T17:07:14+00:00 https://www.aavantgarde.com/en/about/profiles/jason-rhodes/ 2025-09-03T10:15:08+00:00 https://www.aavantgarde.com/en/about/profiles/julian-zachmann/ 2025-11-11T12:50:29+00:00 https://www.aavantgarde.com/en/about/profiles/mario-branciforti/ 2025-11-11T12:50:39+00:00 https://www.aavantgarde.com/en/about/profiles/peter-kaiser/ 2024-12-23T09:15:27+00:00 https://www.aavantgarde.com/en/about/profiles/paola-pozzi/ 2025-11-13T11:17:19+00:00 https://www.aavantgarde.com/en/about/profiles/prof-jean-bennett/ 2025-01-28T10:19:49+00:00 https://www.aavantgarde.com/en/about/profiles/prof-dominik-fischer/ 2025-01-07T13:04:13+00:00 https://www.aavantgarde.com/en/about/profiles/prof-bart-leroy/ 2025-01-31T13:30:51+00:00 https://www.aavantgarde.com/en/about/profiles/dr-mark-pennesi/ 2025-01-07T13:04:01+00:00 https://www.aavantgarde.com/en/about/profiles/prof-srinivas-sadda/ 2025-01-07T13:03:53+00:00 https://www.aavantgarde.com/en/about/profiles/dr-nadia-waheed/ 2025-01-07T13:04:32+00:00 https://www.aavantgarde.com/en/innovation/ 2025-07-19T10:19:29+00:00 https://www.aavantgarde.com/en/innovation/pipeline/ 2025-07-22T16:15:04+00:00 https://www.aavantgarde.com/en/innovation/technology/ 2025-07-18T17:54:20+00:00 https://www.aavantgarde.com/en/innovation/usher-1b/ 2025-01-07T13:11:36+00:00 https://www.aavantgarde.com/en/innovation/stargardt/ 2025-01-07T13:10:22+00:00 https://www.aavantgarde.com/en/clinical-trials/ 2025-12-18T14:05:49+00:00 https://www.aavantgarde.com/en/clinical-trials/luce-1/ 2025-01-07T15:32:27+00:00 https://www.aavantgarde.com/en/clinical-trials/stella/ 2025-07-22T15:08:55+00:00 https://www.aavantgarde.com/en/clinical-trials/celeste/ 2026-04-17T11:19:57+00:00 https://www.aavantgarde.com/en/for-patients/ 2026-06-01T14:50:59+00:00 https://www.aavantgarde.com/en/for-patients/about-irds/ 2026-04-20T15:22:47+00:00 https://www.aavantgarde.com/en/for-patients/aav-gene-therapy-in-inherited-retinal-diseases-irds/ 2026-04-20T15:23:06+00:00 https://www.aavantgarde.com/en/for-patients/what-is-usher-syndrome-type-1b-usher-1b/ 2026-04-20T15:23:09+00:00 https://www.aavantgarde.com/en/for-patients/what-is-stargardt-disease/ 2026-04-20T15:47:24+00:00 https://www.aavantgarde.com/en/for-patients/about-clinical-trials/ 2026-04-20T15:23:16+00:00 https://www.aavantgarde.com/en/for-patients/faqs/ 2026-04-20T15:23:20+00:00 https://www.aavantgarde.com/en/for-patients/patient-resources/ 2026-04-21T08:33:37+00:00 https://www.aavantgarde.com/en/for-patients/expanded-access/ 2026-06-01T14:51:07+00:00 https://www.aavantgarde.com/en/for-patients/explore-our-videos/ 2026-05-08T09:15:49+00:00 https://www.aavantgarde.com/en/news/ 2024-10-28T07:00:31+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-dr-peter-k-kaiser-to-the-board-of-directors/ 2025-01-07T13:14:54+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-michael-heffernan-as-chairman-of-its-board-of-directors/ 2025-01-07T13:14:20+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-dr-doug-kerr-to-the-board-of-directors/ 2025-01-07T13:13:35+00:00 https://www.aavantgarde.com/en/news/aavantgarde-closes-61-million-series-a-financing-to-advance-two-therapeutic-programs-into-the-clinic/ 2025-01-07T13:15:02+00:00 https://www.aavantgarde.com/en/news/aavantgarde-bio-appoints-dr-natalia-misciattelli-as-chief-executive-officer/ 2025-01-07T13:14:38+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-ram-palanki-as-chairman-of-its-board-of-directors/ 2025-01-07T13:15:18+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-the-appointment-of-naveed-shams-md-phd-as-chief-development-and-medical-officer/ 2025-01-07T13:14:46+00:00 https://www.aavantgarde.com/en/news/sofinnova-partners-announces-three-new-investments-from-its-fund-dedicated-to-italian-scientific-research/ 2025-01-07T13:15:47+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-nina-ekaterini-kotsopoulou-phd-as-chief-technical-officer/ 2025-01-07T13:14:07+00:00 https://www.aavantgarde.com/en/news/aavantgarde-presents-large-animal-models-preclinical-data-at-asgct-2024/ 2025-01-07T13:17:03+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-updated-nhp-data-for-its-stargardt-program-to-be-presented-at-arvo-2024/ 2025-01-07T13:16:57+00:00 https://www.aavantgarde.com/en/news/aavantgarde-presents-the-design-of-its-innovative-luce-1-trial-for-ush1b-at-the-9th-annual-retinal-cell-and-gene-therapy-innovation-summit/ 2025-01-07T13:17:09+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-dr-jayashree-sahni-as-chief-medical-officer/ 2025-01-07T13:14:28+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-first-patient-dosed-with-aavb-081-in-fih-phase-12-luce-1-study-for-retinitis-pigmentosa-related-to-ush1b/ 2025-01-07T13:16:43+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-3-oral-presentations-at-esgct-2024/ 2025-01-07T13:17:54+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-ms-lauren-kaskiel-as-chief-business-officer/ 2025-01-07T13:15:28+00:00 https://www.aavantgarde.com/en/news/aavantgarde-founder-and-cso-is-elected-as-president-of-the-european-society-of-gene-and-cell-therapy-esgct/ 2025-01-07T13:15:39+00:00 https://www.aavantgarde.com/en/news/aavantgarde-bio-announces-fda-orphan-drug-designation-for-aavb-081/ 2025-01-07T13:16:09+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-oral-presentation-of-luce-1-clinical-study-at-floretina-2024/ 2025-01-07T13:15:59+00:00 https://www.aavantgarde.com/en/news/aavantgarde-presents-safety-data-of-the-luce-1-study-of-aavb-081-for-rp-related-to-usher-1b/ 2025-01-07T13:15:53+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-2-presentations-at-arvo-2025/ 2025-03-10T08:05:18+00:00 https://www.aavantgarde.com/en/news/aavantgarde-and-tigem-publish-groundbreaking-research-in-science-advances/ 2025-03-31T06:47:45+00:00 https://www.aavantgarde.com/en/news/rasmus-holm-jorgensen-appointed-cfo-at-aavantgarde/ 2025-04-28T11:03:42+00:00 https://www.aavantgarde.com/en/news/aavantgarde-presents-updated-data-of-usher-1b-and-stgd-programs-at-arvo-2025/ 2025-05-12T09:32:23+00:00 https://www.aavantgarde.com/en/news/aavantgarde-receives-fda-ind-clearance-to-progress-stargardt-disease-program-aavb-039/ 2025-07-15T11:00:03+00:00 https://www.aavantgarde.com/en/news/aavantgarde-bio-announces-fda-fast-track-designation-for-aavb-039-for-the-treatment-of-stargardt-disease/ 2025-08-21T13:59:28+00:00 https://www.aavantgarde.com/en/news/aavantgarde-to-present-updated-clinical-data-from-luce-1-study-at-euretina-2025/ 2025-08-28T11:00:03+00:00 https://www.aavantgarde.com/en/news/aavantgarde-presents-updated-positive-clinical-data-from-its-aavb-081-program-for-usher-1b-at-euretina-2025/ 2025-09-05T11:03:29+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-fda-orphan-drug-designation-and-uk-cta-approval-for-aavb-039-for-the-treatment-of-stargardt-disease/ 2025-10-02T11:03:35+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-3-presentations-at-esgct-2025-annual-meeting/ 2025-10-07T07:54:12+00:00 https://www.aavantgarde.com/en/news/aavantgarde-closes-141-million-series-b-financing/ 2025-11-05T10:39:49+00:00 https://www.aavantgarde.com/en/news/aavantgarde-to-present-at-the-44th-annual-jp-morgan-healthcare-conference/ 2026-01-08T12:01:36+00:00 https://www.aavantgarde.com/en/news/aavantgarde-completes-enrollment-in-luce-1-phase-12-clinical-trial-of-aavb-081-for-usher-syndrome-type-b-associated-retinitis-pigmentosa/ 2026-01-15T12:01:55+00:00 https://www.aavantgarde.com/en/news/aavantgarde-appoints-philip-lao-as-senior-vice-president-business-development/ 2026-04-01T11:00:10+00:00 https://www.aavantgarde.com/en/news/aavantgarde-announces-completion-of-recruitment-in-stella-natural-history-study/ 2026-04-21T11:00:24+00:00 https://www.aavantgarde.com/en/news/aavantgarde-to-participate-in-arvo-2026-with-presentations-at-key-pre-events-and-new-clinical-data-from-the-luce-phase-12-study/ 2026-04-23T11:00:03+00:00 https://www.aavantgarde.com/en/careers/ 2025-09-16T12:36:44+00:00 https://www.aavantgarde.com/en/careers/corporate-values/ 2025-06-25T08:29:13+00:00 https://www.aavantgarde.com/en/careers/recruitment-companies/ 2025-01-24T15:55:43+00:00 https://www.aavantgarde.com/en/contact/ 2025-10-09T13:40:46+00:00 https://www.aavantgarde.com/en/privacy-notice/ 2026-01-23T17:15:42+00:00 https://www.aavantgarde.com/en/cookie-policy/ 2024-11-26T14:18:22+00:00 https://www.aavantgarde.com/en/accessibility/ 2024-01-03T14:10:35+00:00